• Maintenance Olaparib Benefits Sustained Beyond 2 Years Treatment

    13 days ago - By Medscape

    Women with newly diagnosed ovarian cancer and a BRCA mutation see sustained benefits in progression free survival rates after two years of maintenance olaparib therapy, a clinical trial analysis suggests.
    Reuters Health Information
    Read more ...